Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.220
-0.100 (-7.58%)
At close: Nov 3, 2026, 4:00 PM EST
1.230
+0.010 (0.82%)
After-hours: Nov 3, 2026, 7:30 PM EST
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $5.4 million as of November 3, 2026. It is the 44,479th most valuable company in the world and the 5,914th biggest in the United States. Its market cap has decreased by 88.75% in one year.
Market Cap
5.40M
Enterprise Value
-4.48M
1-Year Change
-88.75%
Global Rank
Country Rank
#5,914 United States
Category
ChartMarket Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $5.40M, a decrease of -98.48%. That is a compound annual growth rate of -80.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 5.40M | -77.50% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CNS Pharmaceuticals | 6.42M |
| FibroBiologics | 6.40M |
| Processa Pharmaceuticals | 6.20M |
| Aprea Therapeutics | 6.18M |
| Addex Therapeutics | 6.08M |
| Alzamend Neuro | 6.03M |
| XTL Biopharmaceuticals | 5.90M |
| Senti Biosciences Holdings | 5.86M |